R. Phelps

发表

Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancer.

A. Gazdar, D. Ihde, B. Ghosh, 1990, Annals of internal medicine.

myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens.

R. Makuch, A. Gazdar, E. Russell, 1991, Cancer research.

Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.

B. Kramer, J. Minna, A. Gazdar, 1994, Lung cancer.

Smoking Cessation after Successful Treatment of Small-Cell Lung Cancer Is Associated with Fewer Smoking-related Second Primary Cancers

M. Tucker, D. Venzon, D. Ihde, 1993, Annals of Internal Medicine.

Atrial Natriuretic Factor and Arginine Vasopressin Production in T\imor Cell Lines from Patients with Lung Cancer and Their Relationship to Serum Sodium1

S. Steinberg, B. Johnson, D. Ihde, 2006 .

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

S. Steinberg, B. Kramer, A. Gazdar, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.

S. Steinberg, J. Minna, A. Gazdar, 1991, Cancer research.

Different Combination Chemotherapy Regimens Lines from Patients with Small Cell Lung Cancer Treated with Family DNA Amplification in 107 Tumors and Tumor Cell myc

A. Gazdar, E. Russell, D. Ihde, 2006 .

Lung cancer: rational strategies for early detection and intervention.

J. Mulshine, Y. Nakanishi, F. Cuttitta, 1991, Oncology.

MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer

S. Steinberg, A. Gazdar, E. Russell, 1996, Journal of cellular biochemistry. Supplement.

Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.

E. Kohn, E. Sausville, D. Longo, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin

J. Minna, A. Gazdar, H. Pass, 1993 .

NCI‐navy medical oncology branch cell line data base

J. Minna, A. Gazdar, D. Carbone, 1996, Journal of cellular biochemistry. Supplement.

Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer

R. Shoemaker, A. Gazdar, J. Mulshine, 1993, Investigational New Drugs.

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

S. Steinberg, E. Sausville, F. Kaye, 1989, The New England journal of medicine.

Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.

S. Steinberg, J. Mulshine, B. Johnson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non‐small cell lung cancer and small cell lung cancer

S. Steinberg, J. Minna, A. Gazdar, 1996, Journal of cellular biochemistry. Supplement.

Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.

S. Steinberg, J. Minna, A. Gazdar, 1993, Cancer research.

Female patients with small cell lung cancer live longer than male patients.

S. Steinberg, B. Johnson, D. Ihde, 1988, The American journal of medicine.

Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.

S. Steinberg, J. Mulshine, B. Johnson, 1993, Cancer research.

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

I. Linnoila, F. Foss, J. Breneman, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Calcitonin elevation in small cell lung cancer without ectopic production.

D. Venzon, M. Kelley, B. Johnson, 1994, American journal of respiratory and critical care medicine.

MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer

S. Steinberg, A. Gazdar, E. Russell, 1996, Journal of cellular biochemistry. Supplement.

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.

E. Sausville, R. Makuch, J. Minna, 1988, Annals of internal medicine.